Literature DB >> 11596778

Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature.

J J Lin1, G Y Lin, C Shih, W C Shen.   

Abstract

Recent studies have shown unique clinicoradiologic characteristics in patients with hemiballism-hemichorea (HB-HC) caused by non-ketotic hyperglycemia; however, there is still a limited number of patients being reported. We report 7 patients (3 males and 4 females) with this type of dyskinesia, whose ages ranged from 60 to 84 years. Brain CT of these patients showed hyperdensity in the contralateral striatum, corresponding with MRI studies that showed an increased signal intensity on T1-weighted images and a decreased signal on T2-weighted images. After metabolic control had been achieved, the hyperkinetic state of these patients abruptly ceased. Follow-up neuroimaging studies in 2 patients documentied complete resolution of the striatal hyperintensity on brain CT and MRI after 3 months and 6 months, respectively. A review of patients with HB-HC caused by non-ketotic hyperglycemia reported formerly and in the present study shows that the dyskinesia tends to occur in aged diabetic patients. The age of patients with dyskinesia secondary to cerebral infarction is generelly much lower. We also found that 86% (30 out of 35 cases) patients reported with HB-HC caused by non-ketotic hyperglycemia were Asians. The prognosis of the dyskinesia was excellent, and the radiological abnormalities are completely reversible.

Entities:  

Mesh:

Year:  2001        PMID: 11596778     DOI: 10.1007/s004150170089

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Chorea triggered by hyperglycemia in a maternally inherited diabetes and deafness (MIDD) patient with the A3243G mutation of mitochondrial DNA and basal ganglia calcification.

Authors:  Ji-Hoon Kang; Sa-Yoon Kang; Jay-Chol Choi; Seong-Suk Lee; Ji-Soo Kim
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

2.  Prolonged hemiballism after the remission of non-ketotic hyperosmolar syndrome.

Authors:  Yi-Chun Lin; Yen-Chung Lin
Journal:  BMJ Case Rep       Date:  2012-06-28

Review 3.  Chorea-ballism associated with ketotic hyperglycemia.

Authors:  Chunli Chen; Haiping Zheng; Li Yang; Zhiping Hu
Journal:  Neurol Sci       Date:  2014-09-28       Impact factor: 3.307

4.  Unilateral striatal CT and MRI changes secondary to non-ketotic hyperglycaemia.

Authors:  Bushra Johari; Mohammad Hanafiah; Azura Mohamed Mukhari Shahizon; Marymol Koshy
Journal:  BMJ Case Rep       Date:  2014-05-02

5.  Hyperglycemia-induced unilateral basal ganglion lesions with and without hemichorea. A PET study.

Authors:  Jung Lung Hsu; Han-Cheng Wang; Wei-Chih Hsu
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

6.  Irreversible striatal neuroimaging abnormalities secondary to prolonged, uncontrolled diabetes mellitus in the setting of progressive focal neurological symptoms.

Authors:  Chin-Sung Tung; Yuh-Cherng Guo; Chiou-Lian Lai; Li-Min Liou
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

7.  Resolution of acute onset hemichorea-hemiballismus after treatment with intravenous tissue plasminogen activator.

Authors:  D McCollum; S Silvers; S B Dawson; K M Barrett
Journal:  Neurohospitalist       Date:  2013-07

8.  Hemichorea with unilateral MRI striatal hyperintensity in a Saudi patient with diabetes.

Authors:  Khalid W Al-Quliti; Ekhlas S Assaedi
Journal:  Neurosciences (Riyadh)       Date:  2016-01       Impact factor: 0.906

9.  A case of hemichorea-hemiballismus due to nonketotic hyperglycemia.

Authors:  Suja Padmanabhan; Alessandro S Zagami; Ann M Poynten
Journal:  Diabetes Care       Date:  2013-04       Impact factor: 19.112

10.  Non-ketotic hyperglycemia unmasks hemichorea.

Authors:  Abhijeet Danve; Supriya Kulkarni; Girja Bhoite
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.